Sequential Core Stability Corrective Exercise Approach in Lower Crossed Syndrome (SCSCRLCS)

December 8, 2025 updated by: Riphah International University

Sequential Core Stability Corrective Exercise Approach for Alignment And Muscle Function In Lower Crossed Syndrome

The objective of the study will be to determine the effects of Sequential Core Stability Corrective Exercise Approach for Alignment and Muscle Function in Lower Crossed Syndrome.

Study Overview

Detailed Description

Lower Crossed Syndrome is one of common postural disorder which occurs due to the muscular imbalance. It refers to specific altered muscle activation and movement patterns along with some postural deviations. Alterations in muscle activation include overactivity of hip flexors and lower back muscles paired underactivity of abdominals and gluteus muscle. This pattern of imbalance creates dysfunction. Postural correction exercise with inner and outer core muscles are necessary. There are different traditional structural approach, functional approach and biomechanics and are presumed to lead to adjustments in the length and strength of local muscles while ignoring other related malalignments and core stability. The objective of the study will be to determine the effects of Sequential Core Stability Corrective Exercise Approach for Alignment and Muscle Function in Lower Crossed Syndrome.

It will be a randomized controlled trial. Sample size will be collected after running the pilot study. The participants will be recruited through convenient sampling technique and then allocated randomly to Groups. Outcome measures will be alignment and muscle function. Pre and post reading and after one month follow-up will be recorded. Data will be analyzed using statistical package for social sciences software version 25. After assessing normality of data by Shapiro-Wilk test, it will be decided either parametric or nonparametric test will be use within a group or between two groups.

Keywords: Alignment, Core Stability, Diaphragm, Muscular Imbalance, Muscle thickness Pelvic floor.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000
        • Al-khumeini Trust Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 28 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • • Age group between 18 to 28 years

    • No current incidence of low back pain or past history of low back dysfunction
    • Kendall double leg lowering test: Abdominal muscle weakness to the extent of not being able to maintain posterior pelvic tilt during a double leg lowering test in supine position.
    • Diagnosed with lower cross syndrome through assessment criteria of Janda muscle testing and assessment

Exclusion Criteria:

  • • Having any history of low back pain, spinal trauma,

    • Joint dysfunction in past 3 months
    • Congenital deformities at hip or lumbar region,
    • Recent fracture to related joints in past 6 months
    • Any family history of cardiopulmonary disease
    • Any disease or urogenital tract
    • Participants having BMI above 30.
    • Recent history of hepatitis or Fatty liver or
    • Any athlete having high physical activity.
    • History of abdominal, hip or lumbar surgeries in past 3 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: A: Control

Corrective Exercises:

Hip Flexor Stretch, Thoracolumbar Extensor Stretch, Abdominal Curl, and Glute Bridge.

Corrective Exercises: Hip Flexor Stretch, Thoracolumbar Extensor Stretch, Abdominal Curl, and Glute Bridge.
Experimental: B: Sequential Core Stability Corrective Exercise Approach

Sequential Core Stability Corrective Exercise Approach

  1. Corrective Exercises
  2. Diaphragm Training Program
  3. Pelvic floor Muscle training
  4. Core Stability exercises

Sequential Core Stability Corrective Exercise Approach

  1. Corrective Exercises
  2. Diaphragm Training Program
  3. Pelvic floor Muscle training
  4. Core Stability exercises

    1. Beginning
    2. Progressing
    3. Advanced

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Photometry for Pelvic Tilt
Time Frame: Pre (0th week), Post (6th week), (12th week) Follow-up
Angle of Pelvic tilt will be measured Through a Reliable and validated camera.
Pre (0th week), Post (6th week), (12th week) Follow-up
Photometry for Chest Expansion
Time Frame: Pre (0th week), Post (6th week), (12th week) Follow-up
Angle of Chest expansion will be measured at Nipple line, Xiphoid level and at waist level, Through a Reliable and validated camera.
Pre (0th week), Post (6th week), (12th week) Follow-up
Photometry for Cervicothoracic level
Time Frame: Pre (0th week), Post (6th week), (12th week) Follow-up
Angle of C7-T1 will be measured Through a Reliable and validated camera.
Pre (0th week), Post (6th week), (12th week) Follow-up
Photometry for Lumber flexion
Time Frame: Pre (0th week), Post (6th week), (12th week) Follow-up
Angle of Lumber curve will be measured Through a Reliable and validated camera.
Pre (0th week), Post (6th week), (12th week) Follow-up
Diaphragmatic excursion
Time Frame: Pre (0th week), Post (6th week), (12th week) Follow-up
To assess the diaphragmatic motion by M-mode US a 2.5-5 megahertz (MHz) phase array will be used.
Pre (0th week), Post (6th week), (12th week) Follow-up
Levator ani Excursion
Time Frame: Pre (0th week), Post (6th week), (12th week) Follow-up
To assess the pelvic floor motion by M-mode US a 2.5-5 megahertz (MHz) array will be used.
Pre (0th week), Post (6th week), (12th week) Follow-up
Diaphragmatic thickness and thickening
Time Frame: Pre (0th week), Post (6th week), (12th week) Follow-up
diaphragmatic thicknesses and thickening will be assessed by B-mode ultrasonography during various respiratory maneuvers
Pre (0th week), Post (6th week), (12th week) Follow-up
Levator ani thickness and thickening
Time Frame: Pre (0th week), Post (6th week), (12th week) Follow-up
Levator ani thicknesses and thickening will be assessed by B-mode ultrasonography during various respiratory maneuvers
Pre (0th week), Post (6th week), (12th week) Follow-up
Core stability
Time Frame: Pre (0th week), Post (6th week), (12th week) Follow-up
It will be measured by Pressure biofeedback unit for the transverse abdomens.
Pre (0th week), Post (6th week), (12th week) Follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Forced Vital Capacity (FVC)
Time Frame: Pre (0th week), Post (6th week), (12th week) Follow-up
Pulmonary function test through spirometer, It will be measured by digital spirometer.
Pre (0th week), Post (6th week), (12th week) Follow-up
Forced Expiratory Volume per second FEV1
Time Frame: Pre (0th week), Post (6th week), (12th week) Follow-up
Pulmonary function test through spirometer, It will be measured by digital spirometer.
Pre (0th week), Post (6th week), (12th week) Follow-up
Ratio of FEV1/ FVC
Time Frame: Pre (0th week), Post (6th week), (12th week) Follow-up
Pulmonary function test through spirometer, It will be measured by digital spirometer.
Pre (0th week), Post (6th week), (12th week) Follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Wajeeha Zia, PhD*, Riphah International University , QIE, Campus
  • Study Chair: Muhammad Kashif, PhD, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 10, 2024

Primary Completion (Actual)

December 1, 2025

Study Completion (Actual)

December 1, 2025

Study Registration Dates

First Submitted

May 23, 2022

First Submitted That Met QC Criteria

August 17, 2022

First Posted (Actual)

August 18, 2022

Study Record Updates

Last Update Posted (Estimated)

December 15, 2025

Last Update Submitted That Met QC Criteria

December 8, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Control

Subscribe